Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors

Molecular Pharmacology

Volumn 81, Issue 5, 2012, Pages 643-656

  Fazio, F ^a,b   Lionetto, L ^b   Molinaro, G ^a   Bertrand, H O ^c   Acher, F ^d   Ngomba, R T ^a   Notartomaso, S ^a,e   Curini, M ^f   Rosati, O ^f   Scarselli, P ^a   Di Marco, R ^a,e   Battaglia, G ^a   Bruno, V ^a,b   Simmaco, M ^b   Pin, J P ^g,h   Nicoletti, F ^a,b   Goudet, Cyril ^g,h  

^a IRCCS NEUROMED   (Italy)

^b SANT'ANDREA HOSPITAL   (Italy)

^c ACCELRYS INC   (United States)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY OF MOLISE   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

^g UNIV MONTPELLIER   (France)

^h INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CINNABARINIC ACID; DRUG METABOLITE; KYNURENINE; LIPOPOLYSACCHARIDE; METABOTROPIC RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; GENE DELETION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; METABOLITE; MOLECULAR MODEL; MOUSE; MUTAGENESIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ANIMALS; CELLS, CULTURED; CYCLIC AMP; GLUTAMIC ACID; HUMANS; KYNURENINE; MALE; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; OXAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 84859999860     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.074765     Document Type: Article

References (44)

1. Amori L, Guidetti P, Pellicciari R, Kajii Y, and Schwarcz R (2009) On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo. J Neurochem 109:316-325.
2. Aronica E, Dell'Albani P, Condorelli DF, Nicoletti F, Hack N, and Balázs R (1993) Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors. Mol Pharmacol 44:981-989. (Pubitemid 23344964)
3. Battaglia G, Rassoulpour A, Wu HQ, Hodgkins PS, Kiss C, Nicoletti F, and Schwarcz R (2000) Some metabotropic glutamate receptor ligands reduce kynurenate synthesis in rats by intracellular inhibition of kynurenine aminotransferase II. J Neurochem 75:2051-2060.
4. Battaglia G, Busceti CL, Molinaro G, Biagioni F, Traficante A, Nicoletti F, and Bruno V (2006) Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. J Neurosci 26:7222-7229.
5. Bertrand HO, Bessis AS, Pin JP, and Acher FC (2002) Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity. J Med Chem 45:3171-3183.
6. Bessis AS, Rondard P, Gaven F, Brabet I, Triballeau N, Prezeau L, Acher F, and Pin JP (2002) Closure of the Venus flytrap module of mGlu8 receptor and the activation process: Insights from mutations converting antagonists into agonists. Proc Natl Acad Sci USA 99:11097-11102. (Pubitemid 34920885)
7. Bruno V, Battaglia G, Ksiazek I, van der Putten H, Catania MV, Giuffrida R, Lukic S, Leonhardt T, Inderbitzin W, Gasparini F, et al. (2000) Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death. J Neurosci 20:6413-6420.
8. Carpenedo R, Chiarugi A, Russi P, Lombardi G, Carlà V, Pellicciari R, Mattoli L, and Moroni F (1994) Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities. Neuroscience 61:237-243.
9. Chen Y, Goudet C, Pin JP, and Conn PJ (2008) N-{4-Chloro-2-[(1,3-dioxo-1, 3- dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors. Mol Pharmacol 73:909-918. (Pubitemid 351397895)
10. Chen Y, Nong Y, Goudet C, Hemstapat K, de Paulis T, Pin JP, and Conn PJ (2007) Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses. Mol Pharmacol 71:1389-1398. (Pubitemid 46661543)
11. Choi JS, Park HJ, Cha JH, Chung JW, Chun MH, and Lee MY (2003) Induction and temporal changes of osteopontin mRNA and protein in the brain following systemic lipopolysaccharide injection. J Neuroimmunol 141:65-73.
12. Conn PJ, Battaglia G, Marino MJ, and Nicoletti F (2005) Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat Rev Neurosci 6:787-798. (Pubitemid 41679241)
13. Corti C, Battaglia G, Molinaro G, Riozzi B, Pittaluga A, Corsi M, Mugnaini M, Nicoletti F, and Bruno V (2007) The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/ neuroprotection. J Neurosci 27:8297-8308. (Pubitemid 47219630)
14. Dykens JA, Sullivan SG, and Stern A (1987) Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, cinnabarinate, quinolinate and picolinate. Biochem Pharmacol 36:211-217. (Pubitemid 17004917)
15. Fallarino F, Volpi C, Fazio F, Notartomaso S, Vacca C, Busceti C, Bicciato S, Battaglia G, Bruno V, Puccetti P, et al. (2010) Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. Nat Med 16:897- 902.
16. Franklin KB and Paxinos G (1998) The mouse brain in stereotaxic coordinates. Academic Press, London.
17. Frauli M, Hubert N, Schann S, Triballeau N, Bertrand HO, Acher F, Neuville P, Pin JP, and Prézeau L (2007) Amino-pyrrolidine tricarboxylic acids give new insight into group III metabotropic glutamate receptor activation mechanism. Mol Pharmacol 71:704-712.
18. Gobaille S, Kemmel V, Brumaru D, Dugave C, Aunis D, and Maitre M (2008) Xanthurenic acid distribution, transport, accumulation and release in the rat brain. J Neurochem 105:982-993. (Pubitemid 351562747)
19. Goudet C, Gaven F, Kniazeff J, Vol C, Liu J, Cohen-Gonsaud M, Acher F, Prézeau L, and Pin JP (2004) Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors. Proc Natl Acad Sci USA 101:378-383. (Pubitemid 38084258)
20. Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, Candeloro P, Belladonna ML, Bianchi R, Fioretti MC, et al. (2002) CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 3:1097-1101. (Pubitemid 35363664)
21. Gundersen HJ, Jensen EB, Kiêu K, and Nielsen J (1999) The efficiency of systematic sampling in stereologyreconsidered. J Microsc 193:199-211.
22. Hampson DR, Huang XP, Pekhletski R, Peltekova V, Hornby G, Thomsen C, and Thøgersen H (1999) Probing the ligand-binding domain of the mGluR4 subtype of metabotropic glutamate receptor. J Biol Chem 274:33488-33495. (Pubitemid 129511657)
23. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, and Keilp J (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 29:202-209.
24. Henry CJ, Huang Y, Wynne AM, and Godbout JP (2009) Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and antiinflammatory IL-10 cytokines. Brain Behav Immun 23:309-317.
25. Hiramatsu R, Hara T, Akimoto H, Takikawa O, Kawabe T, Isobe K, and Nagase F (2008) Cinnabarinic acid generated from 3-hydroxyanthranilic acid strongly induces apoptosis in thymocytes through the generation of reactive oxygen species and the induction of caspase. J Cell Biochem 103:42-53.
26. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
27. Julio-Pieper M, Flor PJ, Dinan TG, and Cryan JF (2011) Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev 63:35-58.
28. Kessler M, Terramani T, Lynch G, and Baudry M (1989) A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem 52:1319-1328. (Pubitemid 19085960)
29. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275.
30. Maj M, Bruno V, Dragic Z, Yamamoto R, Battaglia G, Inderbitzin W, Stoehr N, Stein T, Gasparini F, Vranesic I, et al. (2003) (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology 45:895-906. (Pubitemid 37297915)
31. Mayhew TM and Gundersen HJ (1996) 'If you assume, you can make an ass out of u and me': a decade of the disector for stereological counting of particles in 3D space. J Anat 188:1-15.
32. Nicoletti F, Wroblewski JT, Novelli A, Alho H, Guidotti A, and Costa E (1986b) The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J Neurosci 6:1905-1911. (Pubitemid 16064954)
33. Nishizuka Y and Hayaishi O (1963) Enzymic synthesis of niacin nucleotides from 3-hydroxyanthranilic acid in mammalian liver. J Biol Chem 238:483-485.
34. Pekhletski R, Gerlai R, Overstreet LS, Huang XP, Agopyan N, Slater NT, Abramow- Newerly W, Roder JC, and Hampson DR (1996) Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. J Neurosci 16:6364-6373. (Pubitemid 26337360)
35. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, and Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55:453-462. (Pubitemid 46383175)
36. Rose K, Goldberg MP, and Choi DW (1992) Cytotoxicity in murine neocortical cell cultures, in Methods in Toxicology (Tyson CA and Frazier JM eds) pp. 46-60, Academic Press, San Diego.
37. Rosemond E, Peltekova V, Naples M, Thøgersen H, and Hampson DR (2002) Molecular determinants of high affinity binding to group III metabotropic glutamate receptors. J Biol Chem 277:7333-7340. (Pubitemid 34953128)
38. Santi MR, Ikonomovic S, Wroblewski JT, and Grayson DR (1994) Temporal and depolarization-induced changes in the absolute amounts of mRNAs encoding metabotropic glutamate receptors in cerebellar granule neurons in vitro. J Neurochem 63:1207-1217. (Pubitemid 24299503)
39. Schoepp DD, Jane DE, and Monn JA (1999) Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38:1431-1476. (Pubitemid 29457728)
40. Schwarcz R and Pellicciari R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303:1-10.
41. Selvam C, Oueslati N, Lemasson IA, Brabet I, Rigault D, Courtiol T, Cesarini S, Triballeau N, Bertrand HO, Goudet C, et al. (2010) A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists. J Med Chem 53:2797-2813.
42. Stone TW and Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609-620. (Pubitemid 37361524)
43. Stone TW and Perkins MN (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol 72:411-412. (Pubitemid 11081065)
44. Wirleitner B, Neurauter G, Schröcksnadel K, Frick B, and Fuchs D (2003) Interferon- gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr Med Chem 10:1581-1591. (Pubitemid 36896559)